ELVN
Enliven TherapeuticsrELVN
$46.53+0.06%24H
ELVN / USDNASDAQ
Use arrow keys to change the interval
NAV$9.95
Liquidity—
Holders3
Circulating Supply0.21
Chains
ProviderReality Finance
P/E Ratio—
Market Cap$3.3B
EPS-1.62
52 Week Range$14.79 – $62.32
Volume$48.08M
Other Issuers—
NameEnliven Therapeutics
TickerrELVN
DividendsNo
Asset ClassStocks
Redemption Fees0.00%
Subscription Fees0.00%
IssuerReality Finance
Custodian—
Crypto Custodian—
Inception—
DomicileEl Salvador
Resolution Country—
About Enliven Therapeutics Inc.

Enliven Therapeutics Inc. (Ticker: ELVN) is an innovative biotechnology company focused on transforming cancer therapies and addressing critical healthcare challenges through its proprietary therapeutic platforms. With a robust pipeline of advanced drug candidates developed using cutting-edge biopharmaceutical technologies, the company is dedicated to enhancing patient care and quality of life. Enliven's commitment to scientific excellence and its mission to fulfill unmet needs in oncology strategically position it for substantial shareholder value while making a meaningful contribution to the healthcare ecosystem.

HeadquartersBURLINGAME, CA

Buy

—
—
Trending
ANTB
Anthropic
$88.438.70%
Details
FXIon
iShares China Large-Cap ETF
$31.241.78%
Details
SPCXB
SpaceX
$127.967.39%
Details

Help